presents
Wheeless' Textbook of Orthopaedics
www.datatrace.com
Tracking Pixel
Search Site by Word
My Account

Ewing's Sarcoma



- See: Bone Tumor Menu

- Discussion:
    - prevalence:
          - it represents approx 7% of all primary bone malignancies;
          - Ewing's sarcoma is more common in males and is rare in blacks;
    - source:
          - uncertain origin;
          - may arise from primitive reticulum cells of marrow;
          - common karyotypic translocation between chromosomes 11 and 22;
    - age:
          - it is a tumor of children & young adults, w/ most cases occurring between ages of 10 and 20 years;
          - 3% of Ewing's sarcoma occurs in children less than 3 years of age;
          - 64% of Ewing's sarcoma occur in the second decade;
    - genetics:
          - expresses p30/32 MIC2 antigen (cell surface glycoprotein);
          - 85% contain chromosomal translocation at the t(11;22)(q24;q12);
    - prognosis:
          - potentially the most lethal of all the bone tumors;
          - most important adverse prognostic factor was metastatic disease detectable at the time of diagnosis;
          - it almost always presents as a stage IIb lesion;
          - before routine use of adjuvant chemo, pts w/ Ewing's were treated w/ XRT alone, & 5 year survival rate was no more than 15%;
          - w/ use of adjuvant chemo, 5 year survival rate to more than 60%;
          - w/ non metastatic Ewing's, disease free survival is 55-70% versus 22-33% for metastatic;
          - pts require careful follow-up, due to post-XRT osteosarcoma;
          - pelvic ewing's:
                - tumors in pelvis are typically detected later & are therefore larger, with a poorer prognosis;
                - 5 year survival rate is about 25%;
    - differential diagnosis:
          - osteomyelitis, osteolytic osteosarcoma, & EOG, & neuroblastoma;
          - in infants and young children, it is necessary to rule out neuroblastoma (only 2% of patients with ewings sarcoma are less than 5 years of age);
                - ewing's sarcoma will stain positve for PAS (cytoplasmic glycogen) and will have a positive vimentin stain;
                - neuroblastoma stains negative for PAS and has a negative vimentin stain, but neuroblastoma is positive for neuron-specific enolase and neurofilament;
          - midshaft lesion w/ large, assoc soft-tissue swelling suggests either infection or Ewing's sarcoma;
          - osteogenic sarcoma tends to be more metaphyseal;
          - ref: Ewings sarcoma masquerading as osteomyelitis. M Durbin MD et al.   CORR. No 357. 1998. p 176.


- Clinical Presentation:
    - may mimic osteomyelitis w/ fever, elevated WBC, & sed rate, wt loss, anemia;
    - enlarging, tender, bony prominence w/ an associated soft tissue mass;
    - sites:
            - femoral diaphysis > pelvis, tibia,   humerus, fibula & ribs;
                  - develops in axial skeleton in large proportion of pts (about 40 %);
            - tumors in pelvis are typically detected later & are therefore larger, with a poorer prognosis;
            - lesion also has peculiar predilection for shaft of fibula
            - an area containing little or no hematopoietic marrow;
            - it occasionally arises in extraosseous sites ("soft-tissue, Ewing's").
            - distant metastases are noted at diagnosis in about 20% of cases;


- Radiographs:
    - permeative diaphyseal tumor w/ mottled, or patchy density;
    - cortical involvement may produce periosteal reaction, "onion skin" pattern;
    - references:
          - Is PET Useful in Detecting Occult Nonpulmonary Metastases in Pediatric Bone Sarcomas?


- Microscopic Features:


- Treatment:
    - treatment consists of chemotherapy, surgical resection & possible XRT;
          - w/ combined therapy pt survival has improved.
    - some authors recommend bone marrow aspiration and biopsy at two or more sites for staging purposes;
    - radiotherapy:
          - approx 75-85 % of primary ewing's tumors are sensitive, depending primarily on tumor size and site;
          - poor to fair results are expect w/ large tumors located in axial skeleton;
          - obviously XRT is not desirable in children because of its effect on the growing limb and because of the
              possibility for causing secondary tumors (can be up to 20%);
    - chemotherapy:
          - vincristine, doxorubicin, cyclophosphamide, adriamycin, ifosfamide, and etoposide;
          - addition of chemotherapy with surgery increases survival to greater than 70% at 5 years;
    - wide surgical excision:
          - preferred over XRT if:
              - involved bone is expendable (eg fibula, rib, clavicle);
              - if XRT would damage growth plate (XRT may cause premature closure of growth plate);
              - if there is pathologic frx;
          - limb salvage w/ insertion of long stem tibial component:

             




- References

Tumor volume as a predictor of necrosis after chemotherapy in Ewing's sarcoma.
      A Abudu et al.   JBJS Vol 81-B. 1999. p 317.

Local and systemic control in Ewing's sarcoma of the femur treated with chemotherapy, and locally by radiotherapy and/or surgery.

Is PET Useful in Detecting Occult Nonpulmonary Metastases in Pediatric Bone Sarcomas?








Original Text by Clifford R. Wheeless, III, MD.